De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis.
Saved in:
| Title: | De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis. |
|---|---|
| Authors: | Stork M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic. stork.martin@fnbrno.cz., Radocha J; Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Mihalyova J; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Spicka I; st Medical Department, Clinical Department of Hematology of the First Faculty of Medicine, General Teaching Hospital Charles University, Prague, Czech Republic., Pika T; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic., Jungova A; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic., Boichuk I; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic., Mensikova K; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic., Straub J; st Medical Department, Clinical Department of Hematology of the First Faculty of Medicine, General Teaching Hospital Charles University, Prague, Czech Republic., Sedlak F; st Medical Department, Clinical Department of Hematology of the First Faculty of Medicine, General Teaching Hospital Charles University, Prague, Czech Republic., Minarik J; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic., Krhovska P; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic., Novakova D; Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Hornakova M; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Knechtova Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic., Sendlerova N; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic., Dekojova T; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic., Maisnar V; Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Jelinek T; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Hajek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Pour L; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic. |
| Source: | Annals of hematology [Ann Hematol] 2025 Aug; Vol. 104 (8), pp. 4141-4147. Date of Electronic Publication: 2025 Aug 18. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40824489 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stork+M%22">Stork M</searchLink>; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic. stork.martin@fnbrno.cz.<br /><searchLink fieldCode="AU" term="%22Radocha+J%22">Radocha J</searchLink>; Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mihalyova+J%22">Mihalyova J</searchLink>; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Spicka+I%22">Spicka I</searchLink>; st Medical Department, Clinical Department of Hematology of the First Faculty of Medicine, General Teaching Hospital Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pika+T%22">Pika T</searchLink>; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Jungova+A%22">Jungova A</searchLink>; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Boichuk+I%22">Boichuk I</searchLink>; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mensikova+K%22">Mensikova K</searchLink>; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Straub+J%22">Straub J</searchLink>; st Medical Department, Clinical Department of Hematology of the First Faculty of Medicine, General Teaching Hospital Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sedlak+F%22">Sedlak F</searchLink>; st Medical Department, Clinical Department of Hematology of the First Faculty of Medicine, General Teaching Hospital Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Minarik+J%22">Minarik J</searchLink>; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Krhovska+P%22">Krhovska P</searchLink>; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Novakova+D%22">Novakova D</searchLink>; Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hornakova+M%22">Hornakova M</searchLink>; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Knechtova+Z%22">Knechtova Z</searchLink>; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sendlerova+N%22">Sendlerova N</searchLink>; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Dekojova+T%22">Dekojova T</searchLink>; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Maisnar+V%22">Maisnar V</searchLink>; Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Jelinek+T%22">Jelinek T</searchLink>; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hajek+R%22">Hajek R</searchLink>; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pour+L%22">Pour L</searchLink>; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2025 Aug; Vol. 104 (8), pp. 4141-4147. <i>Date of Electronic Publication: </i>2025 Aug 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40824489 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-025-06529-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4141 Titles: – TitleFull: De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stork M – PersonEntity: Name: NameFull: Radocha J – PersonEntity: Name: NameFull: Mihalyova J – PersonEntity: Name: NameFull: Spicka I – PersonEntity: Name: NameFull: Pika T – PersonEntity: Name: NameFull: Jungova A – PersonEntity: Name: NameFull: Boichuk I – PersonEntity: Name: NameFull: Mensikova K – PersonEntity: Name: NameFull: Straub J – PersonEntity: Name: NameFull: Sedlak F – PersonEntity: Name: NameFull: Minarik J – PersonEntity: Name: NameFull: Krhovska P – PersonEntity: Name: NameFull: Novakova D – PersonEntity: Name: NameFull: Hornakova M – PersonEntity: Name: NameFull: Knechtova Z – PersonEntity: Name: NameFull: Sendlerova N – PersonEntity: Name: NameFull: Dekojova T – PersonEntity: Name: NameFull: Maisnar V – PersonEntity: Name: NameFull: Jelinek T – PersonEntity: Name: NameFull: Hajek R – PersonEntity: Name: NameFull: Pour L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 104 – Type: issue Value: 8 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |